CTX460
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99434958
- Mark type
- Stylized text
- Filed
- 09 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of lung and liver diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of lung and liver diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of lung and liver diseases or conditions in the field of in vivo gene editing therapy
- Class 042 — Scientific and technological services: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy
Owner
- CRISPR Therapeutics AG, ZUG V8, CH
- CRISPR Therapeutics AG, ZUG V8, CH
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Feb 2026 — ASSIGNED TO EXAMINER
- 25 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Oct 2025 — NEW APPLICATION ENTERED